The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared ...

Chen, who has kept his “overweight” call on REITs, notes that Singapore, as a long-standing and strategic partner of the US, ...

In addition, the company reported a 21% mean weight loss in a higher dose cohort of the 7.2 mg formulation of Wegovy ...

While some food processing is beneficial – such as pasteurising milk to kill bacteria – the ones that cause parents concern ...

The colours that overweight men and women usually wear are the same. For a sleek and stylish fit, one needs to pick the right ...

Around 220,000 people with 'greatest need' are expected to receive Mounjaro through the NHS over the next three years ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and ...

Phase 3 REDEFINE 1 trial found that treatment with CagriSema led to a 22.7% weight loss at 68 weeks among patients who adhered to the treatment, compared ...

Snoring alone could serve as an early sign of high blood pressure, as the poor quality of sleep it induces may heighten the ...

(Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema ...